← Open Payments lookup

DANA LLAMAS: Open Payments

NPI 1467817783 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,278 in 114 payments from 15 companies in 2025. Trend: 2023 $2,183 · 2024 $2,689 · 2025 $2,278

Food & beverage: $2,278
CompanyPaymentsAmount
Incyte Corporation19$451
ABBVIE INC.19$374
UCB, Inc.18$355
Amgen Inc.18$199
GENZYME CORPORATION5$199
Novartis Pharmaceuticals Corporation10$189
Galderma Laboratories, L.P.10$184
Janssen Biotech, Inc.4$76
Boehringer Ingelheim Pharmaceuticals, Inc.2$51
Arcutis Biotherapeutics, Inc.2$49

Products named: OPZELURA, Bimzelx, SKYRIZI, DUPIXENT, OTEZLA, COSENTYX, NEMLUVIO, RINVOQ.

Industry payments across CA — which companies pay providers there.